Emergency MedicineFor COVID-19 plus diabetes, glycemic control tops treatment listJune 15, 2020COVID-19 UpdatesMixed TopicsEndocrinology
Emergency MedicineDiabetes hospitalizations halved with FreeStyle Libre glucose monitorJune 14, 2020Endocrinology
Emergency MedicineHalf of young adults with diabetes have diastolic dysfunctionJune 14, 2020CardiologyEndocrinology
Emergency MedicineEMPA-REG OUTCOME: Empagliflozin cut insulin need in type 2 diabetesJune 13, 2020Endocrinology
Emergency MedicineHalf of type 1 diabetes patients with COVID-19 manage at homeJune 12, 2020COVID-19 UpdatesEndocrinology
Emergency MedicineFDA recalls extended-release metformin due to NDMA impuritiesMay 29, 2020Endocrinology
Emergency Medicine‘The story unfolding is worrisome’ for diabetes and COVID-19May 28, 2020COVID-19 UpdatesPulmonologyMixed TopicsEndocrinology
Emergency MedicineGlucose control linked to COVID-19 outcomes in largest-yet studyMay 15, 2020COVID-19 UpdatesPulmonologyEndocrinology
Emergency MedicineSocieties offer advice on treating osteoporosis patients during pandemicMay 11, 2020COVID-19 UpdatesMixed TopicsEndocrinology
Emergency MedicineFDA approves dapagliflozin for low-EF heart failureMay 7, 2020CardiologyEndocrinology
Emergency MedicineNew study of diabetes drug for COVID-19 raises eyebrowsMay 1, 2020COVID-19 UpdatesPulmonologyMixed TopicsCardiologyEndocrinology
Inflammatory markers may explain COVID-19, diabetes dynamicApril 15, 2020COVID-19 UpdatesEndocrinology
Emergency MedicineDapagliflozin trial in CKD halted because of high efficacyMarch 30, 2020CardiologyEndocrinology
Emergency MedicineLarger absolute rivaroxaban benefit in diabetes: COMPASSMarch 29, 2020CardiologyEndocrinology
